ClinicalTrials.Veeva

Menu

The Relationship Between Adipokines, Obesity and Insulin Resistance in Women With Polycystic Ovarian Syndrome

A

Ain Shams University

Status

Completed

Conditions

Polycystic Ovarian Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT02869750
ADIPCOS

Details and patient eligibility

About

To evaluate possible clinical effects of adipokines , ( ghrelin, resistin and adiponectin), in obese and non-obese patients with polycystic ovary syndrome (PCOS).

Full description

Seventy selected PCOS patients will be recruited for this study, and will be divided into two groups based on their body mass index (BMI): 35 obese (BMI≥ 25 kg/m2, group A), 35 non-obese (BMI<25 kg/m2, group B). In addition, 35 healthy non-obese women (BMI<25 kg/m2) will bw enrolled as the control (group C). Serum levels of FSH (follicle stimulating hormone), LH (luteinizing hormone), T(testosterone), glucose, insulin, adiponectin, resistin and resistin will bw detected, and compared the differences of them among three groups

Enrollment

300 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Females with PCOS in child bearing age who presented at reproductive and endocrinology clinics at Ain Shams University Maternity Hospital

Exclusion criteria

  • Known androgen secreting tumor.
  • PCO on ovarian stimulation medications
  • PCO with any other medical illness.

Trial design

300 participants in 4 patient groups

Obese PCOS
Description:
PCOS patients with BMI more than 25 kg/m2
Lean PCOS
Description:
PCOS patients with BMI less than 25 kg/m2
PCOS with normal HOMA2-1R
Description:
PCOS without Insuline resistance
PCOS with elevated HOMA2-IR
Description:
PCOS with Insuline resistance

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems